LEO Pharma
3
3M
2
0.03
2
0.33
- Areas of investment
Summary
LEO Pharma appeared to be the Corporate Investor, which was created in 1908. The venture was found in North America in United States. The main department of described Corporate Investor is located in the Parsippany.
The common things for fund are deals in the range of 10 - 50 millions dollars. The top activity for fund was in 2018. The fund is constantly included in less than 2 deals per year. The real fund results show that this Corporate Investor is 80 percentage points more often commits exit comparing to other companies.
This organization was formed by August Kongsted.
The standard case for the fund is to invest in rounds with 1 partaker. Despite the LEO Pharma, startups are often financed by LEO Innovation Lab, BridgeBio. In the next rounds fund is usually obtained by LEO Innovation Lab.
Among the most popular portfolio startups of the fund, we may highlight PellePharm. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. We can highlight the next thriving fund investment areas, such as Medical Device, Therapeutics. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
Investments analytics
Analytics
- Total investments
- 3
- Lead investments
- 2
- Rounds per year
- 0.03
- Follow on index
- 0.33
- Investments by industry
- Health Care (3)
- Medical Device (2)
- Information Technology (2)
- mHealth (2)
- Beauty (1) Show 3 more
- Investments by region
-
- Netherlands (2)
- Denmark (1)
- Peak activity year
- 2018
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Group Appearance index
- 0.67
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
| Company name | Deal date | Industry | Deal stage | Deal size | Location |
|---|---|---|---|---|---|
| Noie | 01 Mar 2018 | E-Commerce, Beauty, Cosmetics, Consumer Goods, Health Care | Seed | 0 | Copenhagen, Denmark, Capital Region of Denmark |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.